{
  "$schema": "folio-library-entry/v1",
  "id": "10665-67211",
  "blocks": [
    {
      "id": "library/10665-67211/blocks/prose-sec-000",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Introduire le vaccin contre l’hépatite B dans les services nationaux de vaccination",
      "pageStart": 1,
      "pageEnd": 1,
      "target": "../sections/sec-000-introduire-le-vaccin-contre-lhépatite-b-dans-les.md",
      "narrative": null,
      "content": "",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "empty"
      }
    },
    {
      "id": "library/10665-67211/blocks/prose-sec-001",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Vaccination contre l’hépatite B",
      "pageStart": 1,
      "pageEnd": 1,
      "target": "../sections/sec-001-vaccination-contre-lhépatite-b.md",
      "narrative": null,
      "content": "Généralités\nL’hépatite B (HépB) est un problème de\nsanté publique majeur dans le monde.\nEnviron 30 % de la population mondiale\nest séropositive pour le virus de l’hépatite\nB (HBV), soit 2 milliards d’individus\ninfectés par le HBV. Parmi eux, 350\nmillions sont atteints d’une infection\nchronique à HBV, qui provoque chaque\nannée le décès d’au moins 500 000\npersonnes ayant développé une cirrhose\nou un cancer du foie. Le HBV occupe la\ndeuxième position juste derrière le tabac,\nen tant que cancérogène humain\nreconnu.\nDepuis plus de 20 ans, il existe un\nvaccin contre l’hépatite B dont l’efficacité\net",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Opens a French WHO fact sheet on hepatitis B vaccination by describing hepatitis B as a major global public health problem, with about 2 billion people infected and 350 million chronically infected. It notes that a safe, effective vaccine has existed for over 20 years and could prevent most hepatitis B deaths, and that preventing chronic infection also reduces onward transmission.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-67211/blocks/prose-sec-002",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "DÉPARTEMENT VACCINS ET PRODUITS BIOLOGIQUES",
      "pageStart": 1,
      "pageEnd": 1,
      "target": "../sections/sec-002-département-vaccins-et-produits-biologiques.md",
      "narrative": null,
      "content": "PRODUITS BIOLOGIQUES",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A department heading fragment from the French hepatitis B fact sheet, containing only the words for biological products.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-67211/blocks/prose-sec-003",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Organisation mondiale de la Santé 1211 Genève 27",
      "pageStart": 1,
      "pageEnd": 4,
      "target": "../sections/sec-003-organisation-mondiale-de-la-santé-1211-genève-27.md",
      "narrative": null,
      "content": "1211 Genève 27\n2002\nStratégies vaccinales\nVaccination systématique du nourrisson.\nLa vaccination de tous les nourrissons\ncontre l’hépatite B, en tant que partie\nintégrante dans les calendriers nationaux\nde vaccination infantile est une priorité\ndans tous les pays.  Selon l’épidémiologie\nde la transmission du virus HBV dans un\npays donné, il faut envisager les stratégies\nvaccinales supplémentaires suivantes :\n·\nPrévention de la transmission\npérinatale du virus HBV. Il est\npossible d’empêcher la transmission\nde virus HBV de la mère à l’enfant, en\nadministrant au nouveau-né la\npremière dose de va",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Sets out hepatitis B vaccination strategies in French, giving priority to routine infant vaccination and adding a birth dose where perinatal transmission is common, as in South-East Asia. It explains when catch-up vaccination of older groups makes sense and how monovalent and combined vaccines should be used. It describes three schedule options linked to DTP visits, weighing cost against ease of delivery. It closes with advice on using vaccine introduction to strengthen immunisation services and on budgeting for start-up and recurrent costs; the extracted text contains repeated words and rows of layout symbols.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    }
  ]
}
